Back to Grow Pharma or All Flower/Bud

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This product was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Terpene Profile (Comparative Values)

Myrcene11.8%Herbal/Musk166-168℃
Limonene18.64%Citrus/Sour177℃
Caryophyllene30.22%Pepper/Spice119℃
Humulene7.51%Woody/Earthy107℃
Ocimene12.24%Herbal/Sweet174-175℃
Terpinolene19.58%Floral/Herbal185℃

MedBud currently tracks 16 common terpenes, more will be added.

Medication Details

Brand
United Kingdom Grow Pharma
Designation
T22
Cultivar/Strain
L.A. S.A.G.E.
Classification
Hybrid
Chemotype
Type I: High THC
THC Potential Range (±10%)
22%
CBD Potential Range (±10%)
1%
Cultivated/Produced by
Poland PharmaCann International
Cultivated in
Flag of North Macedonia North Macedonia
Packaged in
Flag of North Macedonia North Macedonia
Imported by
United Kingdom IPS Pharma
Irradiation
Non-Irradiated
Flower Provided
Whole Bud

Stock Availability

We provide stock and pharmacy information for medical cannabis patients only. Cannabis is a controlled substance in the UK and can only be dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed here.

Best Known Status: Available

Main Partner Pharmacy

Pharmacy Wholesaler

Dispensing Pharmacies

Project Twenty21

Available on T21, a research project offering participating patients several discounted medications:

Participating Pharmacies:

Grow Access Project

Available on GAP, an access scheme for veterans and recipients of means-tested benefits:

Participating Pharmacy:
Product DescriptionPatient Reviews

About L.A. S.A.G.E.

LaSHybrid

Three time Cannabis Cup Winner in Amsterdam.

🇳🇱 Dutch Bred, 🇺🇸 American Genetics, 🇦🇫 Afghani Genetics

La S.A.G.E.™ is the ideal strain for all the Sativa lovers who also like to get good production. It was introduced in the Bio-Cup and won 1st place right away. La S.A.G.E.™ is an amazing selection from our regular S.A.G.E.™ strain and a Skunk Sam male from seed. The result is a true Hybrid 60% Sativa/ 40% Indica. It produces dense flowers and it's covered in resin at the end of flowering. La S.A.G.E.™ first entry into the Cannabis Scene came when it was introduced in the Bio-Cup which was judged by the likes of Shanti Baba and Howard Marks a.k.a. Mr Nice. La S.A.G.E.™ won 1st place right away. The following summer it was introduced at the Irún Cup in the Basque country and won 2nd place for Sativa. Then it tested the highest THC of all entries at the last High Times Cannabis Cup in Amsterdam. Three entries - three wins.

Editor Note: SAGE, one of the parent strains is an acronym for: Sativa Afghani Genetic Equilibrium.

Description provided by The Seeds.

Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).

United Kingdom About Grow Group PLC

Grow Pharma Logo

At Grow, we know there are millions of patients who can benefit from cannabis medicines. We aim to cater to as many patients as possible by having the best basket of a variety of high-quality cannabis medicines.

GROW® is a Biopharmaceutical company created back in 2017, focused solely on cannabis-based medicines. Operating in both a vertically integrated and partner model to ensure the optimal, broadest supply of truly differentiated cannabis medicines to really drive the best outcomes for patients.

We put patients at the heart of everything we do.

growgroupplc.com

  New government petition approved: Introduce 'Grow Your Own' Laws for Legal Medical Cannabis Patients (CBPM) — please sign and share. 6 months to achieve 10,000 signatures.

  Information provided is partially community-sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)